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Introduction: Infectious mononucleosis is a clinical syndrome most commonly associated with primary Epstein-Barr
virus infection. The majority of patients with infectious mononucleosis recovers without apparent sequelae.
However, infectious mononucleosis may be associated with several acute complications. In this report we present a
rare case of esophageal rupture that has never been described in the literature before.
Case presentation: We present the case of an 18-year-old Caucasian man affected by severe infectious
mononucleosis complicated by fulminant hepatic failure, splenic rupture and esophageal necrosis.
Conclusions: Although primary Epstein-Barr virus infection is rarely fatal, fulminant infection may occur - in this case
leading to hepatic failure, splenic rupture and esophageal necrosis, subsequently making several surgical interventions
necessary. We show here that infectious mononucleosis is not only a strictly medical condition, but can also lead to
severe surgical complications.
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Infectious mononucleosis (IM) is most often associated
with Epstein-Barr virus (EBV), one of the most common
human viruses, and a member of the family of human her-
pes virus [1]. IM is also called ‘kissing disease’ since infec-
tion with EBV is transmitted mostly via saliva. When
infected during childhood, EBV usually causes only mild
symptoms resulting in a lifelong dormant viral infection
[1]. However, if primary infection occurs during adoles-
cence, EBV leads to IM in 35% to 50% of the cases [2].
Typically, IM leads to the characteristic triad of fever, pha-
ryngitis and lymphadenopathy (cervical, axillary and in-
guinal) that might last for up to several months and can* Correspondence: dbusch@ukaachen.de
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reproduction in any medium, provided the orbe accompanied by splenomegaly. In the rare case of a
severe infection, IM may cause hematologic or neuro-
logical complications, splenic rupture, upper airway ob-
struction, acute myocarditis, as well as mucosal edema
and leads to increased bleeding tendency [2]. Although
primary EBV infection is rarely fatal, fulminant infection
may occur: fatal fulminant hepatitis and fulminant hepatic
failure have been described [3].
We present the uncommon occurrence of a fulminant
hepatic failure, splenic rupture and esophageal necrosis
complicating a primary EBV infection in an 18 year-old
Caucasian man.Case presentation
An 18-year-old Caucasian man was admitted to a per-
ipheral hospital, presenting with a seven-day history of
fever and a deteriorating general condition. An initialtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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dibular and inguinal lymph nodes, enlarged tonsils
and a significant elevation in serum liver enzyme levels.
During the course of hospitalization, he showed a further
increase of serum liver enzymes accompanied by distinct
thrombocytopenia. On the sixth day after hospitalization,
intermittent diffuse, mucosal bleeding with intermittent
hemoptysis and tarry stools occurred. Laboratory testing
showed an impaired coagulation due to deteriorated
liver synthesis. Because of his persistent anemia des-
pite transfusion of four red cell concentrates, a computed
tomography (CT) scan of his thorax and abdomen was
performed, showing pleural effusion, ascites, lymphaden-
opathy with enlarged cecal and portal lymph nodes up to
2.2cm, as well as hepatosplenomegaly (spleen 21cm and
liver 18cm, transversal measurement respectively).
The next day, mucosal bleeding continued and the
condition of the patient worsened. He was subsequently
transferred to the intensive care unit (ICU) of our hospital.
Laboratory parameters on admission showed severely
impaired coagulation (29% prothrombin time (PT), fi-
brinogen not detectable (<0.3g/L), 44% antithrombin III
(AT III), platelets 33G/L) and liver dysfunction (bilirubin
8.2mg/dL, direct bilirubin 5.2mg/dL, albumin 24g/L and
plasma cholinesterase (PCHE) 1540U/L).
Our patient presented with diffuse bleeding of the oro-
pharynx mucosa, which was treated with packing. Bleeding
of the tracheal mucosa caused a significant impairment of
his respiratory situation. Thus protective intubation of our
patient followed. Bronchoscopy was performed and blood
clots were removed. Because of his hemodynamic instabil-
ity, blood transfusion was required.
However, after this episode his hemoglobin levels sta-
bilized. A pulmonary focus after diffuse pulmonary
bleeding was suspected to be the origin of the newly de-
veloping fever (>38.6°C) and he was subsequently treated
with levofloxacin. One day after the initiation of anti-
biotic therapy our patient developed generalized exan-
thema, which quickly spread, progressing in intensity
and turning darker with a more livid discoloration in
the head region over the next three days. Levofloxacin
was stopped and antibiotic therapy was switched to ceftaz-
idime. Suspecting a specific viral infection, further ana-
lyses were performed. Virology was negative for hepatitis
A, B, C virus (HAV, HBV, HCV), human immune defi-
ciency virus (HIV) and cytomegalovirus (CMV), but posi-
tive for EBV infection (1.8 × 7× 105 replications measured
by polymerase chain reaction (PCR)). Because of the ful-
minate course, bacterial superinfection was suspected.
Extensive microbiological screening was performed, but
no specific bacterial or fungal germ could be detected.
Our patient developed increasing amounts of ascites, and
pleural effusions as well as sepsis with a multiorgan dys-
function syndrome (MODS) resulting in liver and kidneyfailure. Due to anuria, hemofiltration was required at this
point.
On the morning of the 21st day after hospitalization
severe oral hemorrhage, with a significant drop in his
hemoglobin level, occurred. Hemorrhagic shock devel-
oped rapidly. The gastric tube showed bloody contents
so diagnostic esophagogastroduodenoscopy was per-
formed. Endoscopy revealed significant arterial bleeding
from a wide ulcer located in the distal esophagus. The
bleeding could not be stopped endoscopically due to the
intensity of the bleeding. An abdominal ultrasound scan
showed moderate amounts of free fluid around the spleen
as well as a central splenic lesion. Suspecting a spontan-
eous splenic rupture, our patient was transferred to the
operating theater immediately. After median laparotomy,
the intraoperative exploration showed massive enlarge-
ment of his spleen and liver. There were two subcapsular
lacerations (Moore grade II) of the liver with a gentle ven-
ous bleeding in segment II/III and IVb, which were suc-
cessfully treated by thermocoagulation. His spleen showed
a grade IV rupture with involvement of the splenic hilus.
Due to hemodynamic instability and general hemorrhagic
diathesis, a splenectomy was performed. Further explor-
ation of the abdomen revealed a covered perforation of
a gastric ulcer in the region of the cardia, which was
closed with a full-thickness running suture using 4/0
polydioxanone. Under intraoperative esophagogastro-
scopy a second bleeding ulcer was reliably identified in
the esophagus and closed by transhiatal full-thickness
suture using 4/0 polydioxanone. Ventral Dor-hemifun-
doplication was performed to adequately support the
esophageal integrity. A left-sided chest tube was inserted
to treat pleural effusion, and a temporary abdominal clos-
ure with an absorbable mesh (vicro) was performed. After
surgery and massive transfusion with a total of 34 red
blood cell concentrates, 40 packs of fresh frozen plasma,
six thrombocyte concentrates and 1000 IU prothrombin
complex (PPSB), our patient was transferred back to
the ICU in a hemodynamically stable condition with only
moderate catecholamine support. Histopathological findings
of tissue samples collected during the surgical intervention
showed gastric mucosal injury from florid inflammation
with bleeding as given in Figure 1. The splenic parenchyma
marked positive against EBV, also shown in Figure 1.
On the fifth postoperative day, there was a transition
of drainage quality and our patient developed recurrent
fever as well as rapidly increasing signs of infection. An
esophagogastroduodenoscopy was performed. The en-
doscopy revealed a full-thickness necrosis of the distal
esophagus from 30 to 38cm. Since there was no chance
of an endoscopic or surgical restitution of the continuity
of the esophagus, a discontinuity resection of the
esophagus with proximal gastrectomy, collar salivary fis-
tula and terminal gastrostomy was performed.
Figure 1 Histological sections from several affected organs. (A) Duodenal and (B) gastric mucosa are injured from florid inflammation with
bleeding. (C) White pulpa of the splenic parenchyma is diminished and paralleled by hyperemia. (D) In the splenic parenchyma some
lymphocytes immunostained against Epstein-Barr virus, latent membrane protein (clone CS.1-4; Dako, Hamburg, Germany) are positive.
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to a very slow regeneration of liver and renal function
as well as persistent respiratory insufficiency due to re-
current pneumonia. Hemofiltration was stopped the 25th
day after surgery when diuresis was gradually restored. On
the 41st postoperative day our patient started spontaneous
breathing and artificial ventilation could be stopped. Our
patient gradually recovered and was transferred to a
standard care unit on the 50th postoperative day. The fur-
ther clinical course was uneventful. Our patient slowly
recovered and could be discharged on the 86th post-
operative day with an epithelialized laparostoma, an enteral
discontinuity with a collar salivary fistula and complete
nourishment via a feeding tube inserted through the
gastrostomy.
Hospital readmission was necessary six months follow-
ing the initial surgery because of cachexia (body mass
index 13kg/m2) due to malnutrition requiring an adjust-
ment of the nutritional protocol. At this time, EBV infec-
tion was still present with a viral load of 4×7×103 GE/mL.
Enteral nutrition was improved and our patient gradually
gained weight and strength.
One year after the discontinuity resection of the esopha-
gus, the reconstruction of the intestinal continuity was per-
formed. Continuity was reconstructed by a retrosternal,
isoperistaltic interposition of the right colon with an end-to-
end esophagocolonic anastomosis, an end-to-end cologastricanastomosis and an end-to-end anastomosis of the ter-
minal ileum and colon transversum.
In the following course the abdominal wall was recon-
structed by a component separation technique according
to Oscar Ramirez [4].
In the further course, our patient developed a collar fis-
tula of the proximal anastomosis and a stenosis of the
esophageal anastomosis of the colon interponat 20 to 25cm
(measured from teeth) with a remaining lumen of 5mm,
which was treated by placement of a covered esophageal
stent. Multiple stent reimplantations followed, with pe-
riods without a stent to avoid pressure necrosis, with a
good result. The stent could finally be removed approxi-
mately three years after the initial surgery.
Our patient has been followed up for more than six
years in our outpatient clinic. Generally, he has almost
completely recovered. Today, he is in an adequate nutri-
tional and general condition. Due to the extensive course
of the disease a consequent socioprofessional reintegration
was required. Unfortunately, since the removal of the
esophageal stent repetitive anastomotic stenoses occurred
(Figure 2), which were treated by endoscopic dilatations
using the Savary-Gilliard technique.
Discussion
We present the successful management of a case of fulmin-
ant IM with extremely aggressive progression. Fulminant
Figure 2 Endoscopic illustration of a stenosis of the esophagocolonic anastomosis that was dilated endoluminally using the
Savary-Gillard technique. A Initial stenosis (7mm), B Result after dilatation and argon-plasma coagulation, C Follow-up showing scar tissue with
re-stenosis, D End-result after recurrent dilatations (12mm).
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with X-linked lymphoproliferative syndrome (XLP) or pa-
tients with immunodeficiency. However, some patients even
develop fatal IM without any obvious preexisting immune
abnormality - as presented in this case [5].
To the best of our knowledge, the combined occurrence
of diffuse mucosal bleeding, splenomegaly with subse-
quent rupture, esophageal and gastric ulceration with
spontaneous perforation, as well as hepatitis with hepatic
failure altogether caused by an EBV infection in an other-
wise healthy man has not been reported until today. Gen-
etic testing to clarify if the patient suffered from XLP was
not performed on our patient.
On primary examination, 50 to 60% of patients with
EBV infection have splenomegaly, with splenic rupture
occurring in 0.5% with a lethality of 30% [6-8]. In these
patients emergency splenectomy is often necessary. Hep-
atomegaly is present in about 10% of adult patients with
primary EBV infection. Mild liver function abnormalities
occur in 80% of the patients and mostly during the sec-
ond week of illness. Mainly, they are self-limiting and re-
solve three weeks after the onset of the disease [6]. Liver
enzymes (aspartate aminotransferase (AST) and alanine
aminotransferase (ALT)) might be increased up to fivefold
values. The level of bilirubin is mostly mildly increased,
which might be due to hemolytic anemia or hepatitis. Only
2% of patients are icteric [6]. Severe liver injury is rare and
can lead to death in acute EBV infection [9,10].
Other cases of renal failure due to EBV infection have
been described [11]. However, whether the renal failureobserved in our case might have been partially due to
aprotinin administration or EBV infection alone remains
unclear. Aprotinin has been used in the treatment of
adult patients with major blood loss during or following
surgery in the past. It was shown to cause renal failure
and therefore was voluntarily withdrawn by the manu-
facturer in 2008.
The development of a deep esophageal and gastric ulcer
through EBV infection has only been described in associ-
ation with AIDS or other immunodeficiencies [12,13]. The
observed mucosal bleeding was most likely due to impaired
coagulation caused by hepatic failure and thrombocytopenia
caused by hypersplenism, as well as local inflammation of
the mucosal tissue. The pronounced inflammation of the
mucosa even led to a deep ulcer of the esophagus with sub-
sequent spontaneous perforation and arterial hemorrhage
making emergency surgical treatment necessary. In the fur-
ther course, impaired wound healing led to necrosis of the
sutured esophagus necessitating resection. This extremely
complicated the course of the disease for the patient.
Antimicrobial therapy with antibiotics was given only
on basis of clinical symptoms, because bacterial or super-
infection was suspected. However, in none of the collected
probes was a bacterial or fungal germ found. Whereas a
benefit of antiviral therapy has been described in some
cases [5], its overall benefit remains unclear. Controlled
trials on treatment with aciclovir in patients with EBV
have shown that treatment neither reduces the severity of
clinical symptoms nor their duration [13,14]. Therefore
no antiviral therapy was administered in our case.
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Although primary EBV infection is rarely fatal, fulminant
infection may occur - in this case leading to hepatic fail-
ure, splenic rupture and esophageal necrosis that re-
quired surgical interventions. Our report shows, that in
rare situations infectious mononucleosis is not only a
medical condition but can also lead to severe complica-
tions including the need for surgical intervention. This
case is an example of successful interdisciplinary manage-
ment of complicated fulminant infectious mononucleosis
in an otherwise healthy 18-year-old Caucasian man.
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